BIO-key International Stock Resumes Trading on Nasdaq
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 18 hours ago
0mins
Source: seekingalpha
- Trading Resumption: BIO-key International's common stock will resume trading on the Nasdaq Capital Market at market open on July 8, 2026, marking a significant milestone in the company's compliance journey.
- Compliance Confirmation: The company confirmed compliance with Nasdaq's continued listing standards, including minimum bid price and SEC filing requirements, following a June 16 hearing, indicating improvements in its governance structure.
- Monitoring Period Extension: BIO-key will operate under a Discretionary Panel Monitor for one year, until July 6, 2027, a measure aimed at ensuring ongoing adherence to market regulations.
- Financial Outlook: Despite reporting a GAAP EPS of -$0.15 and revenue of $2.15 million in Q1, which missed expectations, the company anticipates scaling revenue to between $5 million and $10 million in Q2, indicating potential profitability improvements.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
